Treace Medical Concepts, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 2 | -$0.31 | -$0.29 | -$0.30 |
| Q2 2024 | 2 | -$0.30 | -$0.28 | -$0.29 |
| Q3 2024 | 3 | -$0.28 | -$0.26 | -$0.27 |
| Q4 2024 | 5 | -$0.06 | -$0.02 | -$0.04 |
| Q1 2025 | 3 | -$0.29 | -$0.22 | -$0.25 |
| Q2 2025 | 2 | -$0.25 | -$0.24 | -$0.24 |
| Q3 2025 | 2 | -$0.22 | -$0.21 | -$0.21 |
| Q4 2025 | 2 | -$0.05 | -$0.05 | -$0.05 |
| Q1 2026 | 1 | -$0.32 | -$0.30 | -$0.31 |
| Q2 2026 | 1 | -$0.28 | -$0.26 | -$0.27 |
| Q3 2026 | 1 | -$0.19 | -$0.18 | -$0.18 |
| Q4 2026 | 1 | $0.05 | $0.05 | $0.05 |
Treace Medical Concepts, Inc. Earnings Date And Information
Treace Medical Concepts, Inc. last posted its earnings results on Tuesday, November 5th, 2024. The company reported $-0.25 earnings per share for the quarter, topping analysts' consensus estimates of $-0.27 by $0.02. The company had revenue of 45.09 M for the quarter and had revenue of 187.12 M for the year. Treace Medical Concepts, Inc. has generated $-1 earnings per share over the last year ($-0.81 diluted earnings per share) and currently has a price-to-earnings ratio of -7.45. Treace Medical Concepts, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based on prior year's report dates.
Treace Medical Concepts, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/05/2024 | Q3 2024 | -$0.27 | -$0.25 | 0.02 | $43.48 M | $45.09 M |
| 08/06/2024 | Q2 2024 | -$0.29 | -$0.34 | -0.05 | $43.00 M | $44.46 M |
| 05/07/2024 | Q1 2024 | -$0.30 | -$0.30 | 0 | $51.11 M | |
| 02/27/2024 | Q4 2023 | -$0.09 | -$0.10 | -0.01 | $62.21 M | |
| 11/09/2023 | Q3 2023 | -$0.26 | -$0.28 | -0.02 | $41.64 M | $40.76 M |
| 08/09/2023 | Q2 2023 | -$0.20 | $40.84 M | $41.95 M | ||
| 05/09/2023 | Q1 2023 | -$0.22 | $42.20 M | |||
| 03/08/2023 | Q4 2022 | -$0.06 | $49.77 M | |||
| 11/09/2022 | Q3 2022 | -$0.23 | $30.13 M | $33.06 M | ||
| 08/10/2022 | Q2 2022 | -$0.31 | $28.69 M | $29.97 M | ||
| 05/06/2022 | Q1 2022 | -$0.18 | $29.05 M | |||
| 03/04/2022 | Q4 2021 | -$0.12 | $33.44 M | |||
| 11/04/2021 | Q3 2021 | -$0.12 | -$0.12 | 0 | $21.06 M | $21.62 M |
| 08/05/2021 | Q2 2021 | -$0.12 | -$0.10 | 0.02 | $18.93 M | $20.65 M |
| 05/25/2021 | Q1 2021 | -$0.08 | -$0.05 | 0.03 | $18.71 M | |
| 12/30/2020 | Q4 2020 | $0.05 | $24.11 M | |||
| 09/29/2020 | Q3 2020 | -$0.06 | $14.27 M | |||
| 06/29/2020 | Q2 2020 | -$0.04 | $7.74 M | |||
| 03/30/2020 | Q1 2020 | -$0.04 | $11.26 M |
Treace Medical Concepts, Inc. Earnings: Frequently Asked Questions
-
When is Treace Medical Concepts, Inc.'s earnings date?
Treace Medical Concepts, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, February 25th, 2025 based off last year's report dates.
-
Did Treace Medical Concepts, Inc. beat their earnings estimates last quarter?
In the previous quarter, Treace Medical Concepts, Inc. (:TMCI) reported $-0.25 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.27 by $0.02.
-
How can I listen to Treace Medical Concepts, Inc.'s earnings conference call?
The conference call for Treace Medical Concepts, Inc.'s latest earnings report can be listened to online.
-
How can I read Treace Medical Concepts, Inc.'s conference call transcript?
The conference call transcript for Treace Medical Concepts, Inc.'s latest earnings report can be read online.
-
How much revenue does Treace Medical Concepts, Inc. generate each year?
Treace Medical Concepts, Inc. (:TMCI) has a recorded annual revenue of $187.12 M.
-
How much profit does Treace Medical Concepts, Inc. generate each year?
Treace Medical Concepts, Inc. (:TMCI) has a recorded net income of $187.12 M. Treace Medical Concepts, Inc. has generated $-0.81 earnings per share over the last four quarters.
-
What is Treace Medical Concepts, Inc.'s price-to-earnings ratio?
Treace Medical Concepts, Inc. (:TMCI) has a price-to-earnings ratio of -7.45 and price/earnings-to-growth ratio is -2.53.
